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PValvular Disease
educed Systemic Arterial Compliance
mpacts Significantly on Left Ventricular
fterload and Function in Aortic Stenosis
mplications for Diagnosis and Treatment
artin Briand, MS,* Jean G. Dumesnil, MD, FACC,* Lyes Kadem, ENG, PHD,*†
ntonio G. Tongue, MD,* Régis Rieu, ENG, PHD,† Damien Garcia, ENG, PHD,‡
hilippe Pibarot, DVM, PHD, FACC*
ainte-Foy and Montreal, Quebec, Canada; and Marseille, France
OBJECTIVES We sought to determine to what extent systemic arterial compliance (SAC) might impact on
afterload and left ventricular (LV) function in patients with aortic stenosis (AS).
BACKGROUND Although AS and reduced SAC may often coexist in the same patient, their relative impact
on LV function is not well understood.
METHODS Systemic arterial compliance was calculated as the ratio of stroke volume index to arterial
pulse pressure in 208 patients with at least moderate AS. As a measure of global afterload, we
calculated the valvulo-arterial impedance (Zva), which theoretically accounts for the effects of
both AS and SAC.
RESULTS Patients were divided into four groups: group 1, moderate AS and normal SAC (n  77;
37%); group 2, moderate AS and low SAC (n  50; 24%); group 3, severe AS and normal
SAC (n  45; 22%); and group 4, severe AS and low SAC (n  36; 17%). The prevalences
of LV diastolic and systolic dysfunction were 60% and 6% in group 1, 86% and 12% in group
2, 82% and 16% in group 3, and 94% and 31% in group 4. In multivariate analysis excluding
Zva, energy loss index and SAC were both independent predictors of LV dysfunction, but
when Zva was entered into the analyses, it became the only hemodynamic variable to be
independently associated with LV dysfunction.
CONCLUSIONS Reduced SAC is a frequent occurrence in elderly patients with AS, where it independently
contributes to increased afterload and decreased LV function. Systemic arterial compliance
should be taken into consideration when evaluating these patients with regard to diagnosis
and treatment. (J Am Coll Cardiol 2005;46:291–8) © 2005 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.10.081Cardiology Foundation
e
m
L
T
(
s
a
u
s
r
f
t
A
b
c
m
c
o
d
in patients with aortic stenosis (AS), the occurrence of left
entricular (LV) dysfunction, symptoms, and adverse out-
omes does not always correlate with the classical markers of
emodynamic severity (i.e., valve effective orifice area
See page 299
EOA] and transvalvular pressure gradients). Recently, we
roposed a new index on the basis of valve EOA and
ross-sectional area of the ascending aorta that takes into
ccount the pressure recovery phenomenon (Fig. 1) (1,2).
ence, the energy loss coefficient provides an accurate
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Manuscript received July 16, 2004; revised manuscript received September 28,
004, accepted October 4, 2004.stimation of the net energy loss due to the stenosis and is
ore representative of the increased burden imposed on the
V than the EOA calculated by the continuity equation.
he energy loss coefficient indexed for body surface area
i.e., the energy loss index [ELI]) was also found to be
uperior to either EOA or indexed EOA in predicting
dverse outcomes in patients with AS (1). Although the
tilization of this index resulted in improved sensitivity and
pecificity for the prediction of outcomes, these values
emained below 70%, therefore underlining the need for
urther improvement of risk stratification.
Accelerated arterial stiffening has been linked to hyper-
ension, dyslipidemia, diabetes, and atherosclerosis (3–7).
rterial stiffening reduces the compliance and thus the
uffering function of the systemic arterial system. Reduced
ompliance in the large arterial circulation is regarded as a
ajor factor in the development of systolic hypertension,
ontributing to increased LV afterload and myocardial
xygen demand and to diminished coronary flow during
iastole (4), and it has been shown to be a strong and
ndependent predictor of LV dysfunction and adverse out-
omes (5–8). Patients with AS already have an increased
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Impact of Arterial Compliance in Aortic Stenosis July 19, 2005:291–8fterload due to their valve disease, and it remains to be
etermined whether reduced systemic arterial compliance
SAC) in these patients might not have an additive effect
nd further contribute to deteriorate LV function and
ncrease adverse outcomes. In an acute animal model of
evere AS, we recently observed that a decrease in SAC was
ndeed associated with a marked increase in peak systolic
V wall stress (9). We thus hypothesized that SAC might
ave a significant impact on LV function in AS patients,
iven that the LV faces a double load: valvular  arterial.
he primary objective of this study was, therefore, to
etermine to what extent SAC might impact on afterload
nd LV function in these patients.
ETHODS
atients. The study included 208 consecutive patients (120
en, 88 women, mean age 69  12 years) who underwent
n echocardiographic evaluation and were found to have
oderate or severe AS on the basis of the standards of the
merican Heart Association/American College of Cardiol-
gy (10). On this basis, 97 (47%) had moderate AS (aortic
alve area 1.5 cm2) and 111 (53%) had severe AS (valve
rea 1.0 cm2). Data collected in these patients at the time
f their echocardiographic evaluation included demographic
haracteristics, risks factors for heart disease, and presence
r absence of symptoms (resting dyspnea, exercise dyspnea,
ngina, and/or syncope). Patients with moderate or severe
oexisting aortic regurgitation or moderate or severe mitral
alve disease were excluded. Patients with known hyperten-
ion or coronary artery disease were included because these
onditions are frequent associations in degenerative AS and
re precisely the conditions where SAC might be more
usceptible to decrease. Hypertension was considered to be
resent when there was a history of hypertension requiring
edical therapy. Patients were considered to have signifi-
ant coronary artery disease if they had one of the following
riteria: 1) history of myocardial infarction, coronary angio-
lasty, or coronary artery bypass graft surgery; 2) a  50%
tenosis on at least one epicardial artery on coronary
ngiography; and 3) a regional wall motion abnormality on
Abbreviations and Acronyms
AS  aortic stenosis
BP  blood pressure
EOA  effective orifice area
ELI  energy loss index
LV  left ventricle/ventricular
PP  pulse pressure
SAC  systemic arterial compliance
SAP  systolic arterial pressure
SV  stroke volume
SVi  stroke volume index
Zva  valvulo-arterial impedancechocardiogram.
p
issessment of aortic valve function. Doppler-
chocardiographic measurements included the LV stroke
olume (SV), the peak and mean transvalvular gradients
sing the modified Bernoulli equation, the valve EOA using
he standard continuity equation, and the ELI using this
ormula (Fig. 1):
ELIEOAAAAAEOABSA [1]
here AA is the aortic cross-sectional area calculated from
he diameter of the aorta measured at the sino-tubular
unction, and BSA is the body surface area. The LV stroke
ork loss was expressed as percentage and obtained as: 100
(MG/MG SAP), where MG is the mean transvalvular
ressure gradient and SAP is the systolic brachial artery
ressure (11).
ssessment of LV remodeling. Left ventricular mass was
alculated with the corrected formula of the American
ociety of Echocardiography and was indexed for body
urface area (12). By taking into account both values of LV
ass index and relative wall thickness, patients were classi-
ed into four different LV patterns, as previously described
y Ganau et al. (13).
ssessment of LV systolic function. The LV cardiac
utput was calculated as the product of heart rate and SV
nd was indexed for body surface area. The LV ejection
raction was assessed with the Quinones method (14), the
umesnil method (15), and by visual estimate. In the case
f a disagreement between these methods, the reviewing
ardiologist selected the value that he estimated as being the
ost representative.
ssessment of LV diastolic function. Early (E) transmi-
ral filling peak velocity and transmitral atrial (A) wave
elocity were measured at rest and during phase II of the
alsalva maneuver (16). Diastolic function was classified
igure 1. Schematic representation of the flow and static pressure across
he left ventricular (LV) outflow tract, aortic valve, and ascending aorta
uring systole. AA  aortic cross-sectional area; EOA  effective orifice
rea (i.e., the cross-sectional area of the vena contracta); LVSP  left
entricular systolic pressure; MGnet  transvalvular pressure gradient after
ressure recovery (i.e., net MG); MGvc transvalvular pressure gradient at
he vena contracta; SAP  systolic aortic pressure; SAPvc  systolic aortic
ressure at the vena contracta; SV  stroke volume; SVi  stroke volume
ndex; ZVA  valvulo-arterial impedance.
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July 19, 2005:291–8 Impact of Arterial Compliance in Aortic Stenosisollowing the recommendations of the Canadian Consensus
n Diastolic Dysfunction as follows: normal, impaired
elaxation, pseudonormal, and restrictive pattern (17). A
seudonormal pattern was defined as present if these two
riteria were met: 1) E/A ratio 1 with the Valsalva
aneuver, and 2) decrease in E/A ratio 25% with the
alsalva maneuver (16).
ystemic arterial hemodynamics. Systemic arterial pres-
ure was measured with the use of an arm-cuff sphygmo-
anometer at the same time as SV, measured in the LV
utflow tract by Doppler. Brachial pulse pressure (PP) was
alculated as the difference between systolic and diastolic
rterial pressures. The ratio of SV to PP (SV/PP) was used
s an indirect measure of total SAC (18). Given that it has
een shown that SV/PP is related to body size in normal
dults (7), we also calculated the ratio of SV index to PP
SVi/PP) (8). The systemic vascular resistance was esti-
ated by the formula: (80MAP)/CO, where MAP is the
ean arterial pressure and CO is the cardiac output.
ssessment of global LV afterload. A precise and com-
lete description of the LV afterload imposed by the
ystemic arterial system is provided by the input impedance
pectra of the systemic circulation (19), but this complex
pproach is not feasible in practice. Alternatively, the
rterial impedance can be approximated by the systolic
rterial pressure (SAP) to SVi ratio (20,21). In patients with
S, it is necessary to also take into account the load imposed
y the stenotic valve on the LV. In these patients, the
ncrease in LV systolic pressure may result from the increase
n transvalvular pressure gradient, the increase in SAP (due
o reduced SAC and/or increased systemic vascular resis-
ance), or both abnormalities (Fig. 1). We therefore propose
o estimate global LV afterload in AS patients by the
valvulo-arterial impedance” (Zva) formulated as follows (2):
Zva
SAPMGnet
SVi
[2]
here MGnet is the mean net pressure gradient (i.e., the
ean gradient taking into account pressure recovery), which
as calculated with the equation proposed by Baumgartner
t al. (22). To obtain a more accurate estimate of LV systolic
ressure, it is indeed preferable to add the net pressure
radient rather than the pressure gradient at the vena
ontracta, to the SAP (Fig. 1). As with the stroke work loss,
t was chosen to add the mean rather than the maximal
radient to SAP, because it is closer to the peak-to-peak
radient and will thus provide a better estimate of peak LV
ressure (23,24). Hence, Zva represents the valvular and
rterial factors that oppose ventricular ejection by absorbing
he mechanical energy developed by the LV.
ata analysis and statistics. To better assess the respective
ontributions of the valvular load and the arterial load to the
ariation of LV pattern and function, the patients were
lassified into four different subgroups: group 1, moderate
S and normal SAC defined as ELI 0.55 cm2/m2 and cVi/PP 0.6 ml/m2/mm Hg; group 2, moderate AS and
ow SAC defined as ELI 0.55 cm2/m2 and SVi/PP 0.6
l/m2/mm Hg; group 3, severe AS and normal SAC
efined as ELI 0.55 cm2/m2 and SVi/PP 0.6 ml/
2/mm Hg; and group 4, severe AS and low SAC defined
s ELI 0.55 cm2/m2 and SVi/PP 0.60 ml/m2/mm Hg.
he threshold values used to separate the groups were
elected on the basis of the results reported in previous
tudies (1,2,7). Continuous data were expressed as mean
SD and compared with one-way analysis of variance
SigmaStat 3.0, SPSS Inc., Chicago, Illinois). A Holm-
idak test was used for pair-wise comparisons (25). Cate-
orical data were given as a percentage and compared with
chi-square test. A forward stepwise logistic regression
nalysis was performed to identify the variables that are
ndependently associated with the presence of LV diastolic
nd systolic dysfunction. Variables with a p value 0.1 in
nivariate analysis were entered in multivariate analysis.
ESULTS
able 1 provides a comparison of the clinical, systemic
rterial pressure, and AS severity data in the 208 patients.
he mean age and proportion of women were significantly
igher in group 4 as compared with group 1. Not surpris-
ngly, patients in groups 2 and 4 had a significantly higher
revalence of systemic hypertension than patients in groups
and 3. Patients in group 4 also had a significantly higher
revalence of obesity (body mass index 30 kg/m2) com-
ared with group 1. Overall, the prevalence of symptoms
as highest in group 4 and lowest in group 1, with
ntermediate values being observed in groups 2 and 3.
ortic valve function. Not unexpectedly, the EOA, in-
exed EOA, energy loss coefficient, and ELI were signifi-
antly lower, and peak and mean gradients as well as LV
troke work loss were significantly higher in groups 3 and 4
s compared with groups 1 and 2 (Table 1). It should be
oted, however, that despite similar AS severity in terms of
OA and ELI, patients in group 4 had a significantly lower
V stroke work loss as well as lower peak and mean
radients than the patients in group 3. These findings can
e related to the fact that patients in group 4 had signifi-
antly lower SVs than patients in group 3 (Table 2).
ystemic arterial hemodynamics. By definition, groups 2
nd 4 had reduced SAC, as illustrated by the lower SV/PP
nd SVi/PP, compared with the two other groups (Table 1).
he lower SAC was associated with a higher systolic blood
ressure (BP) and PP in these groups. It should also be
oted that patients in group 4 had significantly lower
ystolic BP and PP compared with the patients in group 2,
lthough SAC was similar in both groups. These findings
an also be related to the fact that the patients in group 4
ad lower SVs than the patients in group 2. Groups 2 and
also had significantly higher systemic vascular resistance
ompared with the two other groups.
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Impact of Arterial Compliance in Aortic Stenosis July 19, 2005:291–8V geometry. There was no significant difference between
roups in regard to LV mass index (Table 2). Patients in
roups 3 and 4, however, had higher relative wall thickness
nd prevalence of LV concentric hypertrophy than patients
n groups 1 and 2.
V diastolic function. Among the 208 patients included
n the study, 160 (77%) were found to have diastolic dysfunc-
ion. The prevalence of diastolic dysfunction was lowest in
roup 1 and highest in group 4, with intermediate values being
bserved in groups 2 and 3 (Table 2, Fig. 2). The variables that
ere independently associated with LV diastolic dysfunction in
ultivariate analysis were: an ELI 0.60 cm2/m2 and a
Vi/PP 0.60 ml/m2/mm Hg (Table 3).
V systolic function. Overall, 29 patients (14%) had a LV
jection fraction 50%. There was no significant difference
mong groups in regard to the average LV ejection fraction,
ut the proportion of patients with a LV ejection fraction
50% was significantly higher in group 4 than in group 1
Table 2, Fig. 2). Patients in group 4 had a significantly
ower SV, mean transvalvular flow rate, and cardiac index,
able 1. Comparison of Demographic, Clinical, Systemic Arteria
Group 1
ELI >0.55 and
SVi/PP >0.60
(n  77; 37%)
ender, n (%)
Males 53 (69)
Females 24 (31)
ge, yrs 67  13
ody surface area, m2 1.81  0.21
o-existing diseases and risk factors
Coronary artery disease 41 (53)
Previous myocardial infarction 20 (26)
Hypertension 43 (56)
Dyslipidemia 38 (49)
Diabetes 15 (19)
Smoking 38 (49)
Obesity 18 (23)
resence of symptoms 50 (65)
ystemic arterial pressure data
Systolic arterial pressure, mm Hg 129  17
Diastolic arterial pressure, mm Hg 74  11
Systolic arterial pressure 140 mm Hg 27 (35)
Pulse pressure, mm Hg 55  13
SV/PP, ml/mm Hg 1.58  0.43
SVi/PP, ml/m2/mm Hg 0.87  0.21
Systemic vascular resistance, dyne·s·cm5 1,467  433
alve stenosis severity
Aortic valve area, cm2 1.15  0.17
Indexed aortic valve area, cm2/m2 0.64  0.12
Energy loss coefficient, cm2 1.32  0.21
Energy loss index, cm2/m2 0.74  0.16
Peak gradient, mm Hg 43  17
Mean gradient, mm Hg 25  11
Percent of stroke work loss 16  6
alvulo-arterial load
Zva, mm Hg/ml/m
2 3.3  0.5
ata are mean  SD or number of patients (%). *Significant difference versus group
SV/PP  ratio of stroke volume to pulse pressure; SVi/PP  ratio of stroke voluompared with the patients in the three other groups; the lroportion of patients with a cardiac index 2.5 l/min/m2
as also higher in group 4 than in groups 1 and 2 (Fig. 2).
t should be pointed out that the differences in LV systolic
unction between groups 3 and 4 were present, although the
egree of AS severity was similar in both groups and, as
videnced by the results for EOA and ELI, they are likely
ue to the fact that the reduction in SAC significantly
ontributed to increased afterload in group 4.
In multivariate analysis, the factors independently asso-
iated with LV systolic dysfunction defined as an LV
jection fraction50% were: the presence of coronary artery
isease, an ELI 0.50 cm2/m2, and a SVi/PP 0.50
l/m2/mm Hg (Table 4). It should be noted that the
hreshold values of ELI and SVi/PP that were the most
iscriminative to predict LV systolic dysfunction were lower
han those used to predict LV diastolic dysfunction. This is
onsistent with the fact that LV diastolic dysfunction
enerally occurs at an earlier stage of the disease when LV
fterload is only moderately increased, whereas LV systolic
ysfunction occurs when there is a more pronounced and
ssure, and Valve Stenosis Severity Data
roup 2 Group 3 Group 4
p Value
>0.55 and
PP <0.60
50; 24%)
ELI <0.55 and
SVi/PP >0.60
(n  45; 22%)
ELI <0.55 and
SVi/PP <0.60
(n  36; 17%)
* 0.04
9 (58) 23 (51) 15 (42)
1 (42) 22 (49) 21 (58)
2  10 70  12 73  7* 0.01
0  0.03 1.79  0.20 1.81  0.21 NS
6 (72) 22 (49) 24 (67) NS
3 (26) 11 (24) 14 (39) NS
1 (82)* 28 (62) 29 (81)* 0.005
6 (52) 21 (47) 21 (58) NS
1 (22) 11 (24) 10 (28) NS
1 (42) 17 (38) 20 (56) NS
6 (32) 14 (31) 19 (53)* 0.02
5 (70) 36 (80) 33 (92)*† 0.02
1  17* 122  15† 145  20*†‡ 0.001
8  11 71  12 73  14 NS
6 (92) 7 (16) 21 (58) 0.001
3  16* 51  13† 72  16*†‡ 0.001
0  0.17* 1.49  0.48† 0.89  0.21*‡ 0.001
0  0.08* 0.83  0.21† 0.49  0.09*‡ 0.001
4  419* 1,487  363† 1,810  384*‡ 0.001
4  0.18 0.70  0.15*† 0.70  0.17*† 0.001
4  0.11 0.39  0.06*† 0.39  0.07*† 0.001
2  0.24 0.77  0.17*† 0.77  0.19*† 0.001
4  0.15 0.43  0.07*† 0.42  0.08*† 0.001
5  14 79  23*† 64  26*†‡ 0.001
1  8 48  16*† 39  18*†‡ 0.001
1  4* 28  7*† 21  6*†‡ 0.001
4  0.9* 4.2  0.7* 5.4  1.1*†‡ 0.001
ignificant difference versus group 2; ‡significant difference versus group 3.
dex to pulse pressure; Zva  valvulo-arterial impedance.l Pre
G
ELI
SVi/
(n 
2
2
7
1.8
3
1
4
2
1
2
1
3
16
7
4
8
0.9
0.5
1,77
1.1
0.6
1.3
0.7
3
2
1
4.ong-standing afterload excess.
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fterload irrespective of the underlying cause. Hence, it was
ighest in the patients of group 4, who had a combination
f both severe AS and low SAC (Table 1, Fig. 3), and
owest in the patients of group 1, who had normal SAC and
nly moderate AS. Interestingly, the patients in group 2
ho had only moderate AS but low SAC had increases of
va similar to those found in the patients of group 3 who
ad severe AS but normal SAC. When Zva was entered in
he multivariate analysis, this variable became the only
igure 2. Comparison of the prevalence of left ventricular (LV) diastolic
nd systolic dysfunction in patients with moderate aortic stenosis (AS) and
ormal systemic arterial compliance (SAC) (group 1), patients with
oderate AS and reduced SAC (group 2), patients with severe AS and
ormal SAC (group 3), and patients with severe AS and reduced SAC
group 4). *Significant difference versus group 1; †significant difference
able 2. Comparison of LV Geometry and Function
Group 1
ELI >0.55 and
SVi/PP >0.60
(n  77; 37%)
ELI
SV
(n
V geometry
LV mass, g 219  77 2
LV mass index, g/m2 119  35 1
Relative wall thickness 0.47  0.09 0.
V remodeling
Normal 28 (41)
LV concentric remodeling 37 (54)
LV hypertrophy—concentric 2 (3)
LV hypertrophy—eccentric 1 (2)
V diastolic function
Diastolic dysfunction 46 (60)
Abnormal relaxation 31 (40)
Pseudo-normal 14 (18)
Restrictive 1 (1)
V systolic function
LV ejection fraction, % 66  10
LV ejection fraction 50% 5 (6)
LV stroke volume, ml 84  18
LV ejection time (ms) 317  45 3
Mean transvalvular flow rate, ml/s 267  58 2
Cardiac index, l/min/m2 2.96  0.70 2.
Cardiac index 2.5 l/min/m2 20 (26)
ata are mean  SD or number of patients (%). *Significant difference versus group
Abbreviations as in Table 1.p
ersus group 2. CI  cardiac index; Dysf.  dysfunction; LV EF  left
entricular ejection fraction.emodynamic factor to be independently associated with
V diastolic and systolic dysfunction (Tables 3 and 4). The
act that the latter analyses no longer yielded SVi/PP and
LI as independent predictors indeed suggests that Zva
dequately represents the respective contribution of these
wo variables to the prediction of LV dysfunction.
ISCUSSION
he major finding of this study is that reduced SAC is a
requent occurrence in patients with AS and that it has a
ajor influence on the occurrence of LV diastolic or systolic
ysfunction. Indeed, the results in our four groups of
atients clearly show that reduced SAC and AS seem to
ave additive effects in increasing afterload and deteriorat-
ng LV function.
The high prevalence of reduced SAC in association with
S should not be surprising given that the most frequent
ause of AS nowadays is degenerative disease of the valve as
t might occur in the elderly as opposed to other previously
ore prevalent causes such as congenital bicuspid valve or
heumatic fever. Moreover, the most frequently mentioned
ypothesis to explain degeneration of the valve in the elderly
s that it is probably due to an atherosclerotic process (26).
therosclerosis is a pathologic process that may involve
arious components of the vascular system including the
orta. In this context, it should be emphasized that the
verage age of our patients was 69  12 years; the patients
n group 4 were significantly older (73  7 years) than the
p 2 Group 3 Group 4
p Value
55 and
<0.60
24%)
ELI <0.55 and
SVi/PP >0.60
(n  45; 22%)
ELI <0.55 and
SVi/PP <0.60
(n  36; 17%)
64 228  64 219  70 NS
30 126  29 120  32 NS
0.09 0.52  0.12* 0.53  0.11* 0.01
9) 6 (17)* 9 (30) 0.04
8) 20 (56) 13 (43) NS
1) 9 (25)* 8 (27)* 0.001
) 1 (2) — NS
6)* 37 (82)* 34 (94)* 0.001
6)* 25 (56) 28 (78)* 0.001
8) 10 (22) 5 (14) NS
) 2 (4) 1 (3) NS
13 68  11 61  15 NS
2) 7 (16) 11 (31)* 0.007
14* 72  16* 62  14*†‡ 0.001
31 319  44 308  32 NS
40* 229  50* 202  44*†‡ 0.001
0.56 2.78  0.62 2.44  0.37*†‡ 0.001
0) 16 (36) 20 (56)*† 0.001
ignificant difference versus group 2; ‡significant difference versus group 3.Grou
>0.
i/PP
 50;
07 
14 
48 
17 (3
21 (4
5 (1
1 (2
43 (8
33 (6
9 (1
1 (2
65 
6 (1
74 
09 
36 
75 
15 (3atients in other groups, which is also consistent with the
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Impact of Arterial Compliance in Aortic Stenosis July 19, 2005:291–8arkedly increased prevalence and severity of atherosclero-
is in elderly patients. These considerations also provide
ustification for not excluding from the present study pa-
ients with risk factors such as hypertension and coronary
rtery disease, because such exclusions would have intro-
uced a bias that would have masked the clinical spectrum
f the disease. Indeed, as for other manifestations of
therosclerosis, “degenerative” AS should be more appro-
riately considered as but one potential manifestation of a
ystemic process rather than a disease solely limited to the
ortic valve. The present findings also suggest that the
athophysiology of AS becomes much more complex when
t is associated with concomitant disease of the aorta and/or
he LV, and that in such instances, a much more sophisti-
ated diagnostic evaluation is required.
linical implications. These results have important clini-
al implications with regard to both the evaluation and
reatment of these patients. Indeed, the aforementioned
onsiderations suggest that degenerative AS is in fact a
uch more complex disease than previously thought and
hat limiting its evaluation to the hemodynamics of the
ortic valve is probably a gross oversimplification that may
ead to erroneous conclusions.
elation between reduced SAC and hypertension. Sys-
olic hypertension and increased PP are the hallmarks of
educed SAC, and the presence of these findings should
lert the clinician that the degenerative process is not
imited to the aortic valve, but also involves the vascular
ystem distal to the valve. It should be emphasized, how-
ver, that there may actually be a pseudo-normalization of
Ps in patients with concomitant LV dysfunction and
educed SV. Hence, it is interesting to note that almost all
92%) patients in group 2 had systolic hypertension, com-
ared with only 58% of patients in group 4 (Table 1). This
Table 3. Independent Predictors of LV Diasto
Variable
Model W
Odd Ratio
(95% CI)
ELI 0.60 cm2/m2 2.9 (1.5–5.8)
SVi/PP 0.60 ml/m2/mm Hg 3.1 (1.5–6.7)
Zva 4.5 mm Hg/ml/m
2 N/A
The output of the model was 0 for normal diastolic function
CI  confidence interval; other abbreviations as in Table
Table 4. Independent Predictors of LV Systoli
Fraction 50%
Variable
Model W
Odds Ratio
(95% CI)
Female gender —
Coronary artery disease 25.2 (3.3–195.
ELI 0.50 cm2/m2 4.5 (1.8–11.5
SVi/PP 0.50 ml/m2/mm Hg 2.9 (1.1–7.6)
Zva 5.0 mm Hg/ml/m
2 N/AAbbreviations as in Table 3.nding is, in all likelihood, owing to the fact that the latter
atients have a much higher prevalence of LV dysfunction
nd that the resulting decreases in SV will tend to decrease
oth systolic pressure and PP. The phenomenon is highly
nsidious, because without calculating SAC one could easily
ave concluded that the arterial hemodynamics of these
atients are normal when, in fact, they are highly abnormal
nd have a significant impact on global LV afterload (Fig.
). Hence, it would seem important to routinely calculate
AC in every patient evaluated for AS. This can be easily
ccomplished at little expense with regard to time, because
P measurements and SV calculations should already be an
ntegral part of the echocardiographic examination of the
atient evaluated for AS.
valuation of afterload and AS severity in patients with
educed SAC. Using an animal model, we recently re-
orted that AS severity may actually be underestimated in
he context of hypertension (9). The results of the present
tudy tend to confirm these findings. Hence, despite similar
egrees of AS severity on the basis of EOA and ELI, the
radients and stroke work loss observed in groups 2 and 4
ere less than those observed in groups 1 and 3, likely due
o lower SVs and mean transvalvular flow rates (Table 2).
he practical implications of these observations are that BP
easurements should be routinely performed when evalu-
ting AS severity and that the evaluation of AS severity
annot be solely limited to gradient measurements, but
hould always include calculation of EOA and ELI. More-
ver, if the BP is elevated, it would seem preferable to repeat
he measurements once the BP has normalized.
Notwithstanding these considerations, the present find-
ngs also demonstrate that a reduced SAC contributes to
ncrease the prevalences of LV dysfunction and symptoms.
rom these data, one can also hypothesize that patients with
ysfunction
ut Zva Model With Zva
p Value
Odd Ratio
(95% CI) p Value
0.003 — —
0.003 — —
N/A 5.4 (2.0–14.3) 0.001
1 for diastolic dysfunction.
sfunction Defined as an LV Ejection
ut Zva Model With Zva
p Value
Odds Ratio
(95% CI) p Value
— 3.5 (1.2–10.3) 0.025
0.001 16.7 (2.2–128.7) 0.007
0.002 — —
0.025 — —
N/A 4.2 (1.7–10.3) 0.001lic D
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July 19, 2005:291–8 Impact of Arterial Compliance in Aortic StenosisS and reduced SAC probably become symptomatic earlier
n the evolution of their disease than patients with pure AS.
ndeed, this hypothesis would seem to be consistent with
he results of Antonini-Canterin et al. (27), who observed
hat hypertensive patients who develop symptoms of AS
ave, on average, larger valve EOAs than normotensive
atients referred with the same symptoms.
anagement of patients with AS and reduced SAC. The
ogical first step in patients with AS and decreased SAC
ould evidently be to aggressively treat their hypertension
nd then to re-evaluate the situation. Further studies will be
ecessary, however, to determine whether significant im-
rovement can be achieved with the intensification of
edical treatment alone. Indeed, optimization of BP levels
ay have its limitations, because SAC may not be com-
letely normalized by treatment. Indeed, patients with
educed SAC often have normal diastolic pressures but
ncreased PPs (e.g., 160/60 mm Hg). Likewise, it may well
e found that it is worthwhile to operate on some of these
atients, although their criteria for AS severity do not meet
urrent guidelines for operation. The rationale behind the
atter attitude could be that total afterload of these patients
s markedly increased and that any significant decrease may
ontribute to the improvement of their prognosis and
ell-being. If the surgical option were contemplated, one
ould have to ensure, however, that the projected operation
ould result in a significant reduction in afterload. In
articular, proper care would have to be taken in order to
void patient-prosthesis mismatch, as previously suggested
28).
In establishing proper clinical conduct, the calculation of
he new parameter introduced in this study (i.e., Zva) might
rove useful to establish critical levels of afterload as well as
o evaluate the effects of the various medical or surgical
nterventions. Hence, the results of this study would suggest
hat a value of Zva 5.0 mm Hg/ml/m
2 might represent a
igure 3. Comparison of the valvulo-arterial impedance (Zva). *Significant
ifference versus group 1; †significant difference versus group 2; ‡signifi-
ant difference versus group 3. Groups definitions as in Figure 2.evel of afterload that exceeds the limit of LV compensatoryechanisms and, therefore, leads to afterload mismatch and
V systolic dysfunction. As well, the value for Zva could be
onfronted to the values of ELI and SVi/PP to determine
he respective contributions of the aortic valve and of the
AC to the afterload excess.
Finally, the results of this study may also contribute to the
xplanation of the suboptimal results of aortic valve replace-
ent with regard to postoperative normalization of LV
iastolic and systolic function. Indeed, previous studies have
eported that postoperative normalization of LV function
ay vary extensively from one patient to another and is
ften incomplete (29). The SAC is generally unchanged by
ortic valve replacement because only the valve, but not the
orta, is replaced at the time of operation.
tudy limitations. The study was retrospective in nature,
nd the data did not allow us to determine the exact time of
ymptom onset in the course of the disease. Likewise, the
ollow-up period was too short to draw any meaningful
onclusions with regard to prognosis. Nonetheless, the data
e present are very compelling in demonstrating that
educed SAC is a frequent occurrence in elderly patients
ith AS and that they pose important new challenges with
egard to diagnostic evaluation and clinical decision making.
ence, it provides a strong impetus for the realization of
urther prospective longitudinal studies to determine
hether the new quantitative indices we propose are better
redictors of symptom onset and clinical outcome than
onventional Doppler-echocardiographic indices. In partic-
lar, such studies would allow verifying whether patients
ith reduced SAC become symptomatic with less severity of
S as compared with patients with normal SAC.
onclusions. Reduced SAC is a frequent occurrence in
lderly patients with AS, where it contributes to increased
fterload and independently contributes to the occurrence of
V dysfunction. This observation should be taken into
onsideration when examining such patients, because it may
mpact significantly on both diagnostic evaluation and
nsuing clinical conduct.
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